These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20650922)

  • 1. Cigarette smoking and chronic liver diseases.
    Altamirano J; Bataller R
    Gut; 2010 Sep; 59(9):1159-62. PubMed ID: 20650922
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic liver diseases for the risk of hepatocellular carcinoma: a case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases.
    Mukaiya M; Nishi M; Miyake H; Hirata K
    Hepatogastroenterology; 1998; 45(24):2328-32. PubMed ID: 9951917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis.
    Di Costanzo GG; De Luca M; Tritto G; Lampasi F; Addario L; Lanza AG; Tartaglione MT; Picciotto FP; Ascione A
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):674-9. PubMed ID: 18679071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
    Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
    Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hepatocellular carcinoma in patients with chronic liver diseases.
    Ciernik IF
    N Engl J Med; 1993 Dec; 329(25):1897; author reply 1897-8. PubMed ID: 8247051
    [No Abstract]   [Full Text] [Related]  

  • 6. The global impact of hepatic fibrosis and end-stage liver disease.
    Lim YS; Kim WR
    Clin Liver Dis; 2008 Nov; 12(4):733-46, vii. PubMed ID: 18984463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Natural course and progression of liver cirhosis in patients with hepatitis C].
    Franke A; Zeuzem S
    Z Gastroenterol; 1998 Jun; 36(6):539-41. PubMed ID: 9675840
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
    Chiba T; Matsuzaki Y; Abei M; Shoda J; Tanaka N; Osuga T; Aikawa T
    Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations of chronic hepatitis B virus infection and cigarette smoking with elevated expression of neu oncoprotein in the development of hepatocellular carcinoma.
    Yu MW; Chen CJ; Luo JC; Brandt-Rauf PW; Carney WP; Santella RM
    Cancer Res; 1994 Oct; 54(19):5106-10. PubMed ID: 7923126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Helicobacter pylori and hepatobiliary diseases].
    Messini F
    Clin Ter; 2003; 154(1):55-6. PubMed ID: 12854285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and prognosis of liver changes associated with cholelithiasis.
    Machnik G
    Morphol Embryol (Bucur); 1979; 25(3):237-40. PubMed ID: 228185
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does increased fatty acid oxidation enhance development of liver cirrhosis and progression to hepatocellular carcinoma in patients with glycogen storage disease type-III?
    Herrema H; Smit GP; Reijngoud DJ; Kuipers F
    J Hepatol; 2007 Aug; 47(2):298-300; author reply 300-1. PubMed ID: 17570555
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatology 2008].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 2008 Jun; 133(25-26):1366-9. PubMed ID: 18553264
    [No Abstract]   [Full Text] [Related]  

  • 15. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
    Sagnelli E; Stroffolini T; Mele A; Almasio P; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
    J Med Virol; 2005 Apr; 75(4):522-7. PubMed ID: 15714480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Juvenile and adult hepatopathy in alpha 1-antitrypsin deficiency].
    Roth SL; Martini GA; Havemann K; Adler G
    Ergeb Inn Med Kinderheilkd; 1981; 46():38-73. PubMed ID: 6262072
    [No Abstract]   [Full Text] [Related]  

  • 17. Preface.
    Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):xiii-xiv. PubMed ID: 19818301
    [No Abstract]   [Full Text] [Related]  

  • 18. Efforts to define the natural history of chronic hepatitis C continue.
    Ghany MG; Seeff LB
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1190-2. PubMed ID: 17045209
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of hepatocellular carcinoma in nonviral-related liver diseases.
    Fan JG; Farrell GC;
    J Gastroenterol Hepatol; 2009 May; 24(5):712-9. PubMed ID: 19646014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma (an approach to the study of risk factors in human cancer).
    London WT
    Ric Clin Lab; 1978; 8(4):232-6. PubMed ID: 216070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.